カテゴリー： QYResearch, 世界

世界のヒト狂犬病ワクチン市場 2019年

【英語タイトル】Global Human Rabies Vaccine Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X09349）・商品コード：DATA909X09349
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：103
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、ヒト狂犬病ワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ベロ細胞狂犬病ワクチン、BHK、ニワトリ胚細胞狂犬病ワクチン、その他に、用途別には、暴露前予防、暴露後予防にセグメント区分し、ヒト狂犬病ワクチンの世界市場を分析しました。


・エグゼクティブ・サマリー
・ヒト狂犬病ワクチンの世界市場概要
・ヒト狂犬病ワクチンの製造コスト構成分析
・ヒト狂犬病ワクチンの開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・ヒト狂犬病ワクチンの地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・ヒト狂犬病ワクチンのセグメント分析（種類別）
（ベロ細胞狂犬病ワクチン、BHK、ニワトリ胚細胞狂犬病ワクチン、その他）
・ヒト狂犬病ワクチンのセグメント分析（用途別）
（暴露前予防、暴露後予防）
・ヒト狂犬病ワクチンの主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Novartis、Sanofi-Pasteur、Chengda、Yisheng、Prcmise、VACN、Changsheng、BCHT、Hissen、）
・ヒト狂犬病ワクチンの市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Human Rabies Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Human Rabies Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Rabies Vaccine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Human Rabies Vaccine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Human Rabies Vaccine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novartis
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others

Segment by Application
Pre-Exposure Prophylaxis
Post-Exposure Prophylaxis

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Human Rabies Vaccine
1.1 Definition of Human Rabies Vaccine
1.2 Human Rabies Vaccine Segment by Type
1.2.1 Global Human Rabies Vaccine Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Vero Cell Rabies Vaccine
1.2.3 BHK
1.2.4 Chick Embryo Cell Rabies Vaccine
1.2.5 Others
1.3 Human Rabies Vaccine Segment by Applications
1.3.1 Global Human Rabies Vaccine Consumption Comparison by Applications (2014-2025)
1.3.2 Pre-Exposure Prophylaxis
1.3.3 Post-Exposure Prophylaxis
1.4 Global Human Rabies Vaccine Overall Market
1.4.1 Global Human Rabies Vaccine Revenue (2014-2025)
1.4.2 Global Human Rabies Vaccine Production (2014-2025)
1.4.3 North America Human Rabies Vaccine Status and Prospect (2014-2025)
1.4.4 Europe Human Rabies Vaccine Status and Prospect (2014-2025)
1.4.5 China Human Rabies Vaccine Status and Prospect (2014-2025)
1.4.6 Japan Human Rabies Vaccine Status and Prospect (2014-2025)
1.4.7 Southeast Asia Human Rabies Vaccine Status and Prospect (2014-2025)
1.4.8 India Human Rabies Vaccine Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Human Rabies Vaccine
2.3 Manufacturing Process Analysis of Human Rabies Vaccine
2.4 Industry Chain Structure of Human Rabies Vaccine

3 Development and Manufacturing Plants Analysis of Human Rabies Vaccine
3.1 Capacity and Commercial Production Date
3.2 Global Human Rabies Vaccine Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Human Rabies Vaccine
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Human Rabies Vaccine Production and Capacity Analysis
4.2 Human Rabies Vaccine Revenue Analysis
4.3 Human Rabies Vaccine Price Analysis
4.4 Market Concentration Degree

5 Human Rabies Vaccine Regional Market Analysis
5.1 Human Rabies Vaccine Production by Regions
5.1.1 Global Human Rabies Vaccine Production by Regions
5.1.2 Global Human Rabies Vaccine Revenue by Regions
5.2 Human Rabies Vaccine Consumption by Regions
5.3 North America Human Rabies Vaccine Market Analysis
5.3.1 North America Human Rabies Vaccine Production
5.3.2 North America Human Rabies Vaccine Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Human Rabies Vaccine Import and Export
5.4 Europe Human Rabies Vaccine Market Analysis
5.4.1 Europe Human Rabies Vaccine Production
5.4.2 Europe Human Rabies Vaccine Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Human Rabies Vaccine Import and Export
5.5 China Human Rabies Vaccine Market Analysis
5.5.1 China Human Rabies Vaccine Production
5.5.2 China Human Rabies Vaccine Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Human Rabies Vaccine Import and Export
5.6 Japan Human Rabies Vaccine Market Analysis
5.6.1 Japan Human Rabies Vaccine Production
5.6.2 Japan Human Rabies Vaccine Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Human Rabies Vaccine Import and Export
5.7 Southeast Asia Human Rabies Vaccine Market Analysis
5.7.1 Southeast Asia Human Rabies Vaccine Production
5.7.2 Southeast Asia Human Rabies Vaccine Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Human Rabies Vaccine Import and Export
5.8 India Human Rabies Vaccine Market Analysis
5.8.1 India Human Rabies Vaccine Production
5.8.2 India Human Rabies Vaccine Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Human Rabies Vaccine Import and Export

6 Human Rabies Vaccine Segment Market Analysis (by Type)
6.1 Global Human Rabies Vaccine Production by Type
6.2 Global Human Rabies Vaccine Revenue by Type
6.3 Human Rabies Vaccine Price by Type

7 Human Rabies Vaccine Segment Market Analysis (by Application)
7.1 Global Human Rabies Vaccine Consumption by Application
7.2 Global Human Rabies Vaccine Consumption Market Share by Application (2014-2019)

8 Human Rabies Vaccine Major Manufacturers Analysis
8.1 Novartis
8.1.1 Novartis Human Rabies Vaccine Production Sites and Area Served
8.1.2 Novartis Product Introduction, Application and Specification
8.1.3 Novartis Human Rabies Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Sanofi-Pasteur
8.2.1 Sanofi-Pasteur Human Rabies Vaccine Production Sites and Area Served
8.2.2 Sanofi-Pasteur Product Introduction, Application and Specification
8.2.3 Sanofi-Pasteur Human Rabies Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Chengda
8.3.1 Chengda Human Rabies Vaccine Production Sites and Area Served
8.3.2 Chengda Product Introduction, Application and Specification
8.3.3 Chengda Human Rabies Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Yisheng
8.4.1 Yisheng Human Rabies Vaccine Production Sites and Area Served
8.4.2 Yisheng Product Introduction, Application and Specification
8.4.3 Yisheng Human Rabies Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Prcmise
8.5.1 Prcmise Human Rabies Vaccine Production Sites and Area Served
8.5.2 Prcmise Product Introduction, Application and Specification
8.5.3 Prcmise Human Rabies Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 VACN
8.6.1 VACN Human Rabies Vaccine Production Sites and Area Served
8.6.2 VACN Product Introduction, Application and Specification
8.6.3 VACN Human Rabies Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Changsheng
8.7.1 Changsheng Human Rabies Vaccine Production Sites and Area Served
8.7.2 Changsheng Product Introduction, Application and Specification
8.7.3 Changsheng Human Rabies Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 BCHT
8.8.1 BCHT Human Rabies Vaccine Production Sites and Area Served
8.8.2 BCHT Product Introduction, Application and Specification
8.8.3 BCHT Human Rabies Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Hissen
8.9.1 Hissen Human Rabies Vaccine Production Sites and Area Served
8.9.2 Hissen Product Introduction, Application and Specification
8.9.3 Hissen Human Rabies Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Human Rabies Vaccine Market
9.1 Global Human Rabies Vaccine Market Trend Analysis
9.1.1 Global Human Rabies Vaccine Market Size (Volume and Value) Forecast 2019-2025
9.2 Human Rabies Vaccine Regional Market Trend
9.2.1 North America Human Rabies Vaccine Forecast 2019-2025
9.2.2 Europe Human Rabies Vaccine Forecast 2019-2025
9.2.3 China Human Rabies Vaccine Forecast 2019-2025
9.2.4 Japan Human Rabies Vaccine Forecast 2019-2025
9.2.5 Southeast Asia Human Rabies Vaccine Forecast 2019-2025
9.2.6 India Human Rabies Vaccine Forecast 2019-2025
9.3 Human Rabies Vaccine Market Trend (Product Type)
9.4 Human Rabies Vaccine Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Human Rabies Vaccine Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Human Rabies Vaccine
Table Global Human Rabies Vaccine Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Human Rabies Vaccine Production Market Share by Types in 2018
Figure Vero Cell Rabies Vaccine Product Picture
Figure BHK Product Picture
Figure Chick Embryo Cell Rabies Vaccine Product Picture
Figure Others Product Picture
Table Global Human Rabies Vaccine Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Human Rabies Vaccine Consumption Market Share by Applications in 2018
Figure Pre-Exposure Prophylaxis
Figure Post-Exposure Prophylaxis
Figure Global Human Rabies Vaccine Revenue (Million USD) (2014-2025)
Figure Global Human Rabies Vaccine Production (K Units) (2014-2025)
Figure North America Human Rabies Vaccine Market Size (Million USD) (2014-2025)
Figure Europe Human Rabies Vaccine Market Size (Million USD) (2014-2025)
Figure China Human Rabies Vaccine Market Size (Million USD) (2014-2025)
Figure Japan Human Rabies Vaccine Market Size (Million USD) (2014-2025)
Figure Southeast Asia Human Rabies Vaccine Market Size (Million USD) (2014-2025)
Figure India Human Rabies Vaccine Market Size (Million USD) (2014-2025)
Table Human Rabies Vaccine Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Human Rabies Vaccine in 2018
Figure Manufacturing Process Analysis of Human Rabies Vaccine
Figure Industry Chain Structure of Human Rabies Vaccine
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Human Rabies Vaccine Manufacturing Plants Distribution
Table Human Rabies Vaccine Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Human Rabies Vaccine Capacity (K Units) of Major Manufacturers (2014-2019)
Table Human Rabies Vaccine Production (K Units) of Major Manufacturers (2014-2019)
Table Human Rabies Vaccine Production Market Share of Major Manufacturers (2014-2019)
Figure Human Rabies Vaccine Production Share by Manufacturers in 2018
Table Human Rabies Vaccine Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Human Rabies Vaccine Revenue Market Share of Major Manufacturers (2014-2019)
Figure Human Rabies Vaccine Revenue Share by Manufacturers in 2018
Table Human Rabies Vaccine Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Human Rabies Vaccine Production by Regions 2014-2019 (K Units)
Table Global Human Rabies Vaccine Production Market Share by Regions 2014-2019
Figure Global Human Rabies Vaccine Production Market Share by Regions in 2018
Table Global Human Rabies Vaccine Revenue by Regions 2014-2019 (Million USD)
Table Global Human Rabies Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Human Rabies Vaccine Revenue Market Share by Regions in 2018
Table Global Human Rabies Vaccine Consumption by Regions 2014-2019 (K Units)
Table Global Human Rabies Vaccine Consumption Market Share by Regions 2014-2019
Figure North America Human Rabies Vaccine Production Growth Rate 2014-2019 (K Units)
Figure North America Human Rabies Vaccine Revenue Growth Rate 2014-2019 (Million USD)
Table North America Human Rabies Vaccine Production, Consumption Import and Export (K Units)
Figure Europe Human Rabies Vaccine Production Growth Rate 2014-2019 (K Units)
Figure Europe Human Rabies Vaccine Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Human Rabies Vaccine Production, Consumption Import and Export (K Units)
Figure China Human Rabies Vaccine Production Growth Rate 2014-2019 (K Units)
Figure China Human Rabies Vaccine Revenue Growth Rate 2014-2019 (Million USD)
Table China Human Rabies Vaccine Production, Consumption Import and Export (K Units)
Figure Japan Human Rabies Vaccine Production Growth Rate 2014-2019 (K Units)
Figure Japan Human Rabies Vaccine Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Human Rabies Vaccine Production, Consumption Import and Export (K Units)
Figure Southeast Asia Human Rabies Vaccine Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Human Rabies Vaccine Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Human Rabies Vaccine Production, Consumption Import and Export (K Units)
Figure India Human Rabies Vaccine Production Growth Rate 2014-2019 (K Units)
Figure India Human Rabies Vaccine Revenue Growth Rate 2014-2019 (Million USD)
Table India Human Rabies Vaccine Production, Consumption Import and Export (K Units)
Figure Global Consumption Human Rabies Vaccine Market Share by Application (2014-2019)
Figure Global Value (Consumption) Human Rabies Vaccine Market Share by Application (2014-2019)
Table Novartis Human Rabies Vaccine Production Sites and Area Served
Table Novartis Human Rabies Vaccine Product Introduction, Application and Specification
Table Novartis Human Rabies Vaccine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Human Rabies Vaccine Production Growth Rate (2014-2019)
Table Novartis Human Rabies Vaccine Production Market Share (2014-2019)
Figure Novartis Human Rabies Vaccine Revenue Market Share (2014-2019)
Table Novartis Human Rabies Vaccine Main Business and Markets Served
Table Sanofi-Pasteur Human Rabies Vaccine Production Sites and Area Served
Table Sanofi-Pasteur Human Rabies Vaccine Product Introduction, Application and Specification
Table Sanofi-Pasteur Human Rabies Vaccine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi-Pasteur Human Rabies Vaccine Production Growth Rate (2014-2019)
Table Sanofi-Pasteur Human Rabies Vaccine Production Market Share (2014-2019)
Figure Sanofi-Pasteur Human Rabies Vaccine Revenue Market Share (2014-2019)
Table Sanofi-Pasteur Human Rabies Vaccine Main Business and Markets Served
Table Chengda Human Rabies Vaccine Production Sites and Area Served
Table Chengda Human Rabies Vaccine Product Introduction, Application and Specification
Table Chengda Human Rabies Vaccine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Chengda Human Rabies Vaccine Production Growth Rate (2014-2019)
Table Chengda Human Rabies Vaccine Production Market Share (2014-2019)
Figure Chengda Human Rabies Vaccine Revenue Market Share (2014-2019)
Table Chengda Human Rabies Vaccine Main Business and Markets Served
Table Yisheng Human Rabies Vaccine Production Sites and Area Served
Table Yisheng Human Rabies Vaccine Product Introduction, Application and Specification
Table Yisheng Human Rabies Vaccine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Yisheng Human Rabies Vaccine Production Growth Rate (2014-2019)
Table Yisheng Human Rabies Vaccine Production Market Share (2014-2019)
Figure Yisheng Human Rabies Vaccine Revenue Market Share (2014-2019)
Table Yisheng Human Rabies Vaccine Main Business and Markets Served
Table Prcmise Human Rabies Vaccine Production Sites and Area Served
Table Prcmise Human Rabies Vaccine Product Introduction, Application and Specification
Table Prcmise Human Rabies Vaccine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Prcmise Human Rabies Vaccine Production Growth Rate (2014-2019)
Table Prcmise Human Rabies Vaccine Production Market Share (2014-2019)
Figure Prcmise Human Rabies Vaccine Revenue Market Share (2014-2019)
Table Prcmise Human Rabies Vaccine Main Business and Markets Served
Table VACN Human Rabies Vaccine Production Sites and Area Served
Table VACN Human Rabies Vaccine Product Introduction, Application and Specification
Table VACN Human Rabies Vaccine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table VACN Human Rabies Vaccine Production Growth Rate (2014-2019)
Table VACN Human Rabies Vaccine Production Market Share (2014-2019)
Figure VACN Human Rabies Vaccine Revenue Market Share (2014-2019)
Table VACN Human Rabies Vaccine Main Business and Markets Served
Table Changsheng Human Rabies Vaccine Production Sites and Area Served
Table Changsheng Human Rabies Vaccine Product Introduction, Application and Specification
Table Changsheng Human Rabies Vaccine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Changsheng Human Rabies Vaccine Production Growth Rate (2014-2019)
Table Changsheng Human Rabies Vaccine Production Market Share (2014-2019)
Figure Changsheng Human Rabies Vaccine Revenue Market Share (2014-2019)
Table Changsheng Human Rabies Vaccine Main Business and Markets Served
Table BCHT Human Rabies Vaccine Production Sites and Area Served
Table BCHT Human Rabies Vaccine Product Introduction, Application and Specification
Table BCHT Human Rabies Vaccine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table BCHT Human Rabies Vaccine Production Growth Rate (2014-2019)
Table BCHT Human Rabies Vaccine Production Market Share (2014-2019)
Figure BCHT Human Rabies Vaccine Revenue Market Share (2014-2019)
Table BCHT Human Rabies Vaccine Main Business and Markets Served
Table Hissen Human Rabies Vaccine Production Sites and Area Served
Table Hissen Human Rabies Vaccine Product Introduction, Application and Specification
Table Hissen Human Rabies Vaccine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Hissen Human Rabies Vaccine Production Growth Rate (2014-2019)
Table Hissen Human Rabies Vaccine Production Market Share (2014-2019)
Figure Hissen Human Rabies Vaccine Revenue Market Share (2014-2019)
Table Hissen Human Rabies Vaccine Main Business and Markets Served
Figure Global Human Rabies Vaccine Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Human Rabies Vaccine Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Human Rabies Vaccine Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Human Rabies Vaccine Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Human Rabies Vaccine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Human Rabies Vaccine Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Human Rabies Vaccine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Human Rabies Vaccine Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Human Rabies Vaccine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Human Rabies Vaccine Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Human Rabies Vaccine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Human Rabies Vaccine Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Human Rabies Vaccine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Human Rabies Vaccine Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Human Rabies Vaccine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Human Rabies Vaccine by Type (2019-2025)
Table Global Consumption (K Units) of Human Rabies Vaccine by Application (2019-2025)
Table Human Rabies Vaccine Distributors List
Table Human Rabies Vaccine Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Novartis、Sanofi-Pasteur、Chengda、Yisheng、Prcmise、VACN、Changsheng、BCHT、Hissen、

★調査レポート[世界のヒト狂犬病ワクチン市場 2019年] (コード：DATA909X09349)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のヒト狂犬病ワクチン市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の狂犬病治療市場 2019年
    DATA909X14016 / QYResearch / 2019年11月20日 / ※本調査レポートは、狂犬病治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、細胞培養ワクチン（CCV）、狂犬病免疫グロブリン（RIG）、神経組織ワクチン（NTV）に、用途別には、暴露前予防、暴露後予防にセグメント区分し、狂犬病治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・狂犬病治療の世界市場概要 ・狂犬病治療の製造コスト構成分析 ・狂犬病治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・狂犬病治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・狂犬病治療のセグメント分析（種類別） （細胞培養ワクチン（CCV）、狂犬病免疫グロブリン（RIG）、神経組織ワクチン（NTV））...The global Rabies Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rabies Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rabies Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Rabies Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Rabies Treatment manufacturing...
  • 世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場 2019年
    DATA909X09338 / QYResearch / 2019年11月20日 / ※本調査レポートは、ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CSJ-148、CyMVectin、TRL-345、PPCM、サイトメガロウイルスワクチン、その他に、用途別には、感染症、腫瘍学、女性の健康、その他にセグメント区分し、ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの世界市場概要 ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの製造コスト構成分析 ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bのセグメント分析（種類別） （CSJ-148、CyMVectin、TRL-345、PPCM、サイトメガロウイルスワクチン、その他）...The global Human Cytomegalovirus Envelope Glycoprotein B market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Human Cytomegalovirus Envelope Glycoprotein B volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Cytomegalovirus Envelope Glycoprotein B market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Human Cytomegalovirus Envelope Glycoprotein B in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の不活化ポリオウイルスワクチン市場 2019年
    DATA909X09581 / QYResearch / 2019年11月20日 / ※本調査レポートは、不活化ポリオウイルスワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ヒト2倍体細胞、サル腎培養細胞に、用途別には、パブリック、プライベートにセグメント区分し、不活化ポリオウイルスワクチンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・不活化ポリオウイルスワクチンの世界市場概要 ・不活化ポリオウイルスワクチンの製造コスト構成分析 ・不活化ポリオウイルスワクチンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・不活化ポリオウイルスワクチンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・不活化ポリオウイルスワクチンのセグメント分析（種類別） （ヒト2倍体細胞、サル腎培養細胞）...The global Inactivated Poliovirus Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Inactivated Poliovirus Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Inactivated Poliovirus Vaccine market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Inactivated Poliovirus Vaccine in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のポリオウイルスワクチン不活化市場 2019年
    DATA909X13249 / QYResearch / 2019年11月20日 / ※本調査レポートは、ポリオウイルスワクチン不活化の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ヒト二倍体細胞、猿腎臓細胞に、用途別には、パブリック、プライベートにセグメント区分し、ポリオウイルスワクチン不活化の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ポリオウイルスワクチン不活化の世界市場概要 ・ポリオウイルスワクチン不活化の製造コスト構成分析 ・ポリオウイルスワクチン不活化の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ポリオウイルスワクチン不活化の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ポリオウイルスワクチン不活化のセグメント分析（種類別） （ヒト二倍体細胞、猿腎臓細胞）...The global Poliovirus Vaccine Inactivated market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Poliovirus Vaccine Inactivated volume and value at global level, regional level and company level. From a global perspective, this report represents overall Poliovirus Vaccine Inactivated market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Poliovirus Vaccine Inactivated in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の7価肺炎球菌ワクチン市場 2019年
    DATA909X02781 / QYResearch / 2019年11月22日 / ※本調査レポートは、7価肺炎球菌ワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、単回投与バイアル、充填済みシリンジに、用途別には、病院、クリニックにセグメント区分し、7価肺炎球菌ワクチンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・7価肺炎球菌ワクチンの世界市場概要 ・7価肺炎球菌ワクチンの製造コスト構成分析 ・7価肺炎球菌ワクチンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・7価肺炎球菌ワクチンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・7価肺炎球菌ワクチンのセグメント分析（種類別） （単回投与バイアル、充填済みシリンジ）...The global 7-Valent Pneumococcal Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on 7-Valent Pneumococcal Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall 7-Valent Pneumococcal Vaccine market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of 7-Valent Pneumococcal Vaccine in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の子宮頸がんワクチン市場 2019年
    DATA909X05339 / QYResearch / 2019年11月15日 / ※本調査レポートは、子宮頸がんワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ガーダシル、セルバリックスに、用途別には、HPV6、HPV11、HPV16、HPV18にセグメント区分し、子宮頸がんワクチンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・子宮頸がんワクチンの世界市場概要 ・子宮頸がんワクチンの製造コスト構成分析 ・子宮頸がんワクチンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・子宮頸がんワクチンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・子宮頸がんワクチンのセグメント分析（種類別） （ガーダシル、セルバリックス）...The global Cervical Cancer Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cervical Cancer Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cervical Cancer Vaccine market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Cervical Cancer Vaccine in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の10価肺炎球菌多糖ワクチン市場 2019年
    DATA909X02631 / QYResearch / 2019年11月22日 / ※本調査レポートは、10価肺炎球菌多糖ワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、単回投与バイアル、充填済みシリンジに、用途別には、病院、クリニックにセグメント区分し、10価肺炎球菌多糖ワクチンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・10価肺炎球菌多糖ワクチンの世界市場概要 ・10価肺炎球菌多糖ワクチンの製造コスト構成分析 ・10価肺炎球菌多糖ワクチンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・10価肺炎球菌多糖ワクチンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・10価肺炎球菌多糖ワクチンのセグメント分析（種類別） （単回投与バイアル、充填済みシリンジ）...The global 10-Valent Pneumococcal Polysaccharide Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on 10-Valent Pneumococcal Polysaccharide Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall 10-Valent Pneumococcal Polysaccharide Vaccine market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of 10-Valent Pneumococcal Polysaccharide Vaccine in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の帯状疱疹ワクチン市場 2019年
    DATA909X18098 / QYResearch / 2019年11月22日 / ※本調査レポートは、帯状疱疹ワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、生、組換えに、用途別には、政府機関、民間部門、その他にセグメント区分し、帯状疱疹ワクチンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・帯状疱疹ワクチンの世界市場概要 ・帯状疱疹ワクチンの製造コスト構成分析 ・帯状疱疹ワクチンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・帯状疱疹ワクチンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・帯状疱疹ワクチンのセグメント分析（種類別） （生、組換え）...The global Zoster Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Zoster Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Zoster Vaccine market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Zoster Vaccine in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Zoster Vaccine manufacturing...

    • ◆H&Iグローバルリサーチのお客様（例）◆